AbbVie announces CHMP recommendation for Tepkinly in follicular lymphoma
AbbVie has announced that its IgG1-bispecific antibody Tepkinly (epcoritamab) has been recommended by the European Medicines Agency’s human medicines committee to treat specific cases of follicular lymphoma (FL). The Committee for Medicinal Products for …